Gepretix is indicated for adjunctive use with an oestrogen in post-menopausal women with an intact uterus, as hormone replacement therapy (HRT).1
Adverse events should be reported. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Exeltis UK Limited on 01494 411775 or by email to uk.medinfo@exeltis.com
| Pack size2 | 30 capsules |
| Price | £4.62 |
| PIP | 540-1419 |
| GTIN | 08437024360056 |
Gepretix 100 mg soft capsules Summary of Product Characteristics
BNF. Available at: https://bnf.nice.org.uk/drugs/progesterone/medicinal-forms/ (Accessed October 2024)
Company info
